Cargando…

Full-length versus intact PTH concentrations in pseudohypoparathyroidism type 1 and primary hyperparathyroidism: clinical evaluation of immunoassays in individuals from China

PURPOSE: The application of the third-generation parathyroid hormone (PTH) assay [PTH(1–84) assay] for evaluating PTH levels in patients with pseudohypoparathyroidism type-1 (PHP1) is less popular than the second-generation assay. Therefore, we aimed at examining the conformity between the PTH(1–84)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Yi, Song, Ailing, Song, An, Hu, Yingying, Jiang, Yan, Li, Mei, Xia, Weibo, Xing, Xiaoping, Cheng, Xinqi, Wang, Ou
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9553086/ https://www.ncbi.nlm.nih.gov/pubmed/36220966 http://dx.doi.org/10.1007/s12020-022-03204-7

Ejemplares similares

The whole-PTH/intact-PTH ratio is a useful predictor of severity of secondary hyperparathyroidism
por: Tanaka, Motoko, et al.
Publicado: (2008)

Decreased expression of calcium-sensing receptor and parafibromin in secondary hyperparathyroidism with an abnormal whole PTH/intact PTH ratio
por: Yamada, Shunsuke, et al.
Publicado: (2013)

Comparing the values of intact parathormone and 1– 84 PTH to predict hyperparathyroidism in hemodialysis patients
por: Jenabi, Aria, et al.
Publicado: (2017)

Explorative research on glucolipid metabolism and levels of adipokines in pseudohypoparathyroidism type 1 patients
por: Yang, Yi, et al.
Publicado: (2023)

Pseudohypoparathyroidism: a diagnosis to consider once a PTH elevation is detected
por: Brambilla, Ilaria, et al.
Publicado: (2022)

Tertiary hyperparathyroidism in patients with pseudohypoparathyroidism type 1a
por: Itoh, Masatsune, et al.
Publicado: (2022)

Neonatal transient pseudohypoparathyroidism: could it be included among inactivating parathyroid hormone (PTH)/PTH-related protein signalling disorders?
por: De Rose, Domenico Umberto, et al.
Publicado: (2019)

Diagnostic Accuracy Study of Intraoperative and Perioperative Serum Intact PTH Level for Successful Parathyroidectomy in 501 Secondary Hyperparathyroidism Patients
por: Zhang, Lina, et al.
Publicado: (2016)

Resistance to GHRH but Not to PTH in a 15-Year-Old Boy With Pseudohypoparathyroidism 1A
por: Munteanu, Martin, et al.
Publicado: (2019)

Acetate free citrate-containing dialysate increase intact-PTH and BAP levels in the patients with low intact-PTH
por: Kuragano, Takahiro, et al.
Publicado: (2013)

Neonatal and Early Infancy Features of Patients With Inactivating PTH/PTHrP Signaling Disorders/Pseudohypoparathyroidism
por: Del Sindaco, Giulia, et al.
Publicado: (2023)

Manifestations of left ventricular dysfunction and arrhythmia in patients with chronic hypoparathyroidism and pseudohypoparathyroidism: a preliminary study
por: Wang, Yabing, et al.
Publicado: (2020)

Comparison of Intact PTH and Bio-Intact PTH Assays Among Non-Dialysis Dependent Chronic Kidney Disease Patients
por: Einbinder, Yael, et al.
Publicado: (2017)

Pseudohypoparathyroidism type I‐b with neurological involvement is associated with a homozygous PTH1R mutation
por: Guerreiro, R., et al.
Publicado: (2016)

Functional Properties of Two Distinct PTH1R Mutants Associated With Either Skeletal Defects or Pseudohypoparathyroidism
por: Portales‐Castillo, Ignacio, et al.
Publicado: (2022)

Intraoperative parathyroid hormone (PTH) testing in patients with primary hyperparathyroidism and PTH levels in the normal range
por: Medas, Fabio, et al.
Publicado: (2019)

The preliminary study on cardiac structure and function in Chinese patients with primary hyperparathyroidism
por: Chen, Rong, et al.
Publicado: (2023)

Inverse correlation of intact PTH, oxidized PTH as well as non-oxidized PTH with 25-hydroxyvitamin D3 in kidney transplant recipients
por: Zuo, Jiao, et al.
Publicado: (2023)

Role of intraoperative PTH monitoring and surgical approach in primary hyperparathyroidism
por: Khan, Angela A., et al.
Publicado: (2015)

PTH-dependence of the effectiveness of cinacalcet in hemodialysis patients with secondary hyperparathyroidism
por: Akizawa, Tadao, et al.
Publicado: (2016)

Improving the Accuracy and Reliability of Parathyroid Hormone Levels Through the Mass-Spectrometric Measurement of Full-length PTH and C-Terminal PTH Fragments
por: Ulmer, Candice Z, et al.
Publicado: (2021)

Ectopic Intact PTH Secretion Causing Humoral Hypercalcemia of Malignancy
por: Rauf, Mohammad Talha, et al.
Publicado: (2021)

The Usefulness of Intraoperative PTH as a Predictor for Successful Parathyroidectomy in Secondary Hyperparathyroidism
por: Chávez, Karla Verónica, et al.
Publicado: (2021)

Chemical Characterization and Quantification of Circulating Intact PTH and PTH Fragments by High-Resolution Mass Spectrometry in Chronic Renal Failure
por: Kritmetapak, Kittrawee, et al.
Publicado: (2021)

Management of pseudohypoparathyroidism
por: Germain-Lee, Emily L.
Publicado: (2019)

Clinical and Genetic Analysis of Multiple Endocrine Neoplasia Type 1-Related Primary Hyperparathyroidism in Chinese
por: Kong, Jing, et al.
Publicado: (2016)

Malignant Hypercalcemia Induced by the Ectopic Production of Intact Parathyroid Hormone (PTH)
por: Neves, Ana, et al.
Publicado: (2023)

The Current Role of Parathyroid Fine-Needle Biopsy (P-FNAB) with iPTH-Washout Concentration (iPTH-WC) in Primary Hyperparathyroidism: A Single Center Experience and Literature Review
por: Obołończyk, Łukasz, et al.
Publicado: (2022)

Needle aspirate PTH in diagnosis of primary hyperparathyroidism due to intrathyroidal parathyroid cyst
por: Dutta, Deep, et al.
Publicado: (2013)

Intraoperative PTH cutoff definition to predict successful parathyroidectomy in secondary and tertiary hyperparathyroidism
por: Ohe, Monique Nakayama, et al.
Publicado: (2015)

Serum PTH reference values in an adult Brazilian population: implications for the diagnosis of hyperparathyroidism
por: Rosario, Pedro Weslley, et al.
Publicado: (2019)

Reversed whole PTH/intact PTH ratio as an indicator of marked parathyroid enlargement: five case studies and a literature review
por: Komaba, Hirotaka, et al.
Publicado: (2008)

Full-blown hyperparathyroidism
por: Bae, Woo Kyun, et al.
Publicado: (2018)

Whole‐genome sequencing revealed a novel long‐range deletion mutation spanning GNAS in familial pseudohypoparathyroidism
por: Fei, Yangfan, et al.
Publicado: (2023)

Pseudohypoparathyroidism during pregnancy and the postpartum period: A case series of five patients
por: Wang, Jia-Jia, et al.
Publicado: (2022)

Purinergic Signaling Mediates PTH and Fluid Flow-Induced Osteoblast Proliferation
por: Xing, Yanghui, et al.
Publicado: (2021)

Update on the efficacy, safety, and adherence to treatment of full length parathyroid hormone, PTH (1-84), in the treatment of postmenopausal osteoporosis
por: Pietrogrande, Luca
Publicado: (2010)

MON-533 Irisin in Post-Menopausal Women with Primary Hyperparathyroidism: An Interplay between Irisin and Pth
por: Palermo, Andrea, et al.
Publicado: (2019)

Immunoassay-based quantification of full-length peptidylglycine alpha-amidating monooxygenase in human plasma
por: Ilina, Yulia, et al.
Publicado: (2023)

Pseudohypoparathyroidism: phenotypic spectrum in kindred
por: Natino, Antonette A A, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_efegkes5qq4776dhas0334f2n0